172 related articles for article (PubMed ID: 27384481)
1. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Kang JH; Lee SH; Lee JS; Nam B; Seong TW; Son J; Jang H; Hong KM; Lee C; Kim SY
Oncotarget; 2016 Aug; 7(31):49397-49410. PubMed ID: 27384481
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
Kang JH; Lee SH; Hong D; Lee JS; Ahn HS; Ahn JH; Seong TW; Lee CH; Jang H; Hong KM; Lee C; Lee JH; Kim SY
Exp Mol Med; 2016 Nov; 48(11):e272. PubMed ID: 27885254
[TBL] [Abstract][Full Text] [Related]
3. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.
Park J; Shim JK; Kang JH; Choi J; Chang JH; Kim SY; Kang SG
Neuro Oncol; 2018 Jun; 20(7):954-965. PubMed ID: 29294080
[TBL] [Abstract][Full Text] [Related]
4. Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC.
Lee S; Lee JS; Seo J; Lee SH; Kang JH; Song J; Kim SY
Sci Rep; 2018 Oct; 8(1):15707. PubMed ID: 30356107
[TBL] [Abstract][Full Text] [Related]
5. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Lee JS; Kang JH; Lee SH; Hong D; Son J; Hong KM; Song J; Kim SY
Cell Death Dis; 2016 Dec; 7(12):e2511. PubMed ID: 27929535
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in
Lee SH; Jeon Y; Kang JH; Jang H; Lee H; Kim SY
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481524
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation.
Lee JS; Kim SH; Lee S; Kang JH; Lee SH; Cheong JH; Kim SY
Sci Rep; 2019 Nov; 9(1):16313. PubMed ID: 31705020
[TBL] [Abstract][Full Text] [Related]
9. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
10. Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.
Lee JS; Lee H; Lee S; Kang JH; Lee SH; Kim SG; Cho ES; Kim NH; Yook JI; Kim SY
EBioMedicine; 2019 Feb; 40():184-197. PubMed ID: 30686754
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres.
Park HH; Park J; Cho HJ; Shim JK; Moon JH; Kim EH; Chang JH; Kim SY; Kang SG
Molecules; 2021 Jan; 26(2):. PubMed ID: 33429981
[TBL] [Abstract][Full Text] [Related]
12. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
Wang J; Xia S; Zhu Z
Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
[TBL] [Abstract][Full Text] [Related]
14. Effect of gossypol on kinetics of mouse liver alcohol and aldehyde dehydrogenase.
Messiha FS
Gen Pharmacol; 1991; 22(4):573-6. PubMed ID: 1936890
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
Lee I; Kalota A; Gewirtz AM; Shogen K
Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247
[TBL] [Abstract][Full Text] [Related]
16. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
[TBL] [Abstract][Full Text] [Related]
17. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II.
Wei L; Dai Q; Zhou Y; Zou M; Li Z; Lu N; Guo Q
Biochim Biophys Acta; 2013 Jun; 1830(6):3835-45. PubMed ID: 23500080
[TBL] [Abstract][Full Text] [Related]
18. [Redox and phosphorylation equilibrium of the central metabolic pathway: rat liver profile in controls and after treatment with dichloroacetate and phenformin following dichloroacetate].
Cingolani ML; Bastianelli P; Cannelli B; Salvucci MP
Boll Soc Ital Biol Sper; 1980 May; 56(10):1097-102. PubMed ID: 7448013
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
Okumura S; Sasaki T; Minami Y; Ohsaki Y
J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer.
Yang Z; Zhang SL; Hu X; Tam KY
Eur J Pharmacol; 2018 Nov; 838():41-52. PubMed ID: 30213498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
